Skip to main content

Advertisement

SpringerLink
Log in

The results of pars plana vitrectomy and silicone oil tamponade for endophthalmitis after intravitreal injections

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

To report the role of early vitrectomy and silicone oil tamponade in acute endophthalmitis following intravitreal injection. Medical records of eight patients who presented with acute endophthalmitis after intravitreal injection of different drugs were retrospectively reviewed. Initial treatment consisted of vitreous tap with cultures and injection of intravitreal antibiotics, with the patients subsequently undergoing pars plana vitrectomy and silicone oil tamponade within 24 h following initial vitreous tap. The mean time to presentation was 1.7 days (1–3 days). The initial best-corrected visual acuity was hand motion to 0.05 before treatment and 0.05–0.8 (Snellen) after treatment. Vitreous cultures were obtained from all patients, of which four were culture positive. Endophthalmitis was controlled in all patients. There was no retinal detachment or phthisis bulbi during the follow-up period (1–4 years). Acute endophthalmitis following intravitreal injection occurs rapidly and requires urgent treatment. If intravitreal antibiotics fail to control inflammation, early pars plana vitrectomy and silicone oil tamponade would be an appropriate option.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Shah CP, Garg SJ, Vander JF et al (2011) Post-Injection Endophthalmitis (PIE) Study Team. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 118(10):2028–2034

    Article  PubMed  Google Scholar 

  2. Pharmakakis NM, Petropoulos IK, Georgakopoulos CD et al (2009) Apoptotic mechanisms within the retina in Staphylococcus epidermidis experimental endophthalmitis. Graefes Arch Clin Exp Ophthalmol 247:667–674

    Article  PubMed  CAS  Google Scholar 

  3. Goldberg RA, Flynn HW Jr, Isom RF et al (2012) An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol 153(2):204–208

    Article  PubMed  CAS  Google Scholar 

  4. Kuhn F, Gini G (2005) Ten years after… are findings of the endophthalmitis vitrectomy study still relevant today? Graefes Arch Clin Exp Ophthalmol 243(12):1197–1199

    Article  PubMed  Google Scholar 

  5. Macugen Diabetic Retinopathy Study Group (2005) A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112:1747–1757

    Article  Google Scholar 

  6. Heier JS, Antoszyk AN, Pavan PR et al (2006) Ranibizumab for treatment of neovascular age-related macular degeneration. A phase I/II multicenter, controlled, multidose study. Ophthalmology 113:642

    Article  Google Scholar 

  7. Nelson ML, Tennant MT, Sivalingam A et al (2003) Infectious and presumed noninfectious endophthalmitis after intravitrealtriamcinolone acetonide injection. Retina 23(5):686–691

    Article  PubMed  Google Scholar 

  8. Eifrig CW, Flynn HW Jr, Scott IU, Newton J (2002) Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995–2001). Ophthalmic Surg Lasers 33(5):373–378

    PubMed  Google Scholar 

  9. Cohen SM, Flynn HW Jr, Murray TG, Smiddy WE (1995) Endophthalmitis after pars plana vitrectomy. The postvitrectomy endophthalmitis study group. Ophthalmology 102(5):705–712

    PubMed  CAS  Google Scholar 

  10. Moshfeghi DM, Kaiser PK, Scott IU et al (2003) Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136(5):791–796

    Article  PubMed  CAS  Google Scholar 

  11. Veritti D, Di Giulio A, Sarao V, Lanzetta P (2012) Drug safety evaluation of intravitreal triamcinolone acetonide. Expert Opin Drug Saf 11(2):331–340 Epub 2011 Nov 9

    Article  PubMed  CAS  Google Scholar 

  12. Mason JO 3rd, White MF, Feist RM et al (2008) Incidence of acute onset endophthalmitis following intravitreal bevacizumab (avastin) injection. Retina 28(4):564–567

    Article  PubMed  Google Scholar 

  13. Fintak DR, Shah GK, Blinder KJ et al (2008) Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 28(10):1395–1399

    Article  PubMed  Google Scholar 

  14. Kuhn F, Gini G (2006) Vitrectomy for endophthalmitis. Ophthalmology 113(4):714

    Article  PubMed  Google Scholar 

  15. Ozdamar A, Aras C, Ozturk R et al (1999) In vitro antimicrobial activity of silicone oil against endophthalmitis-causing agents. Retina 19(2):122–126

    Article  PubMed  CAS  Google Scholar 

  16. Zimmer-Galler IE, Santos A, Haller JA, Campochiaro PA (1997) Management of endophthalmitis in a silicone oil-filled eye. Retina 17:507–509

    PubMed  CAS  Google Scholar 

  17. Kaynak S, Oner FH, Koçak N, Cingil G (2003) Surgical management of postoperative endophthalmitis: comparison of 2 techniques. J Cataract Refract Surg 29(5):966–969

    Article  PubMed  Google Scholar 

  18. Yan H, Lu Y, Yu J et al (2008) Silicone oil in the surgical treatment of traumatic endophthalmitis. Eur J Ophthalmol 18(5):680–684

    PubMed  CAS  Google Scholar 

  19. Dotrelová D, Dvorák J, Kalvodová B, Stĕpánková J (2003) Pars plana vitrectomy and primary implantation of silicone oil in the treatment of acute exogenous endophthalmitis in eyes without retinal detachment. Cesk Slov Oftalmol 59(3):146–152

    PubMed  Google Scholar 

  20. Bali E, Huyghe P, Caspers L, Libert J (2003) Vitrectomy and silicone oil in the treatment of acute endophthalmitis. Preliminary results. Bull Soc Belge Ophtalmol 288:9–14

    PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no commercial or proprietary interest in any of the products mentioned in this report. No conflicting relationship exists for any author.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, School of Medicine, Baskent University, Istanbul, Turkey

    Eylem Yaman Pinarci

  2. Department of Ophthalmology, School of Medicine, Baskent University, Ankara, Turkey

    Nilufer Yesilirmak, Sezin Akca Bayar, Imren Akkoyun & Gursel Yilmaz

  3. Department of Ophthalmology, School of Medicine, Baskent University, Adana, Turkey

    Selcuk Sizmaz

  4. Baraj yolu Caddesi, Agaoglu Eltes Güneşi, B2-39 Dudullu, Ümraniye, Istanbul, Turkey

    Eylem Yaman Pinarci

Authors
  1. Eylem Yaman Pinarci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nilufer Yesilirmak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sezin Akca Bayar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Selcuk Sizmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Imren Akkoyun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gursel Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eylem Yaman Pinarci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pinarci, E.Y., Yesilirmak, N., Bayar, S.A. et al. The results of pars plana vitrectomy and silicone oil tamponade for endophthalmitis after intravitreal injections. Int Ophthalmol 33, 361–365 (2013). https://doi.org/10.1007/s10792-012-9702-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9702-6

Keywords

Search

Navigation